1. Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA;
2. Harvard Medical School, Boston, MA;
3. Broad Institute, Cambridge, MA;
4. Program in Health Sciences and Technology, Harvard Medical School–Massachusetts Institute of Technology, Boston, MA;
5. Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark;
6. Translational Immunogenomics Laboratory, Dana Farber Cancer Institute, Boston, MA;
7. Moores Cancer Center, University of California San Diego, La Jolla, CA;
8. Department of Health Sciences Research and
9. Department of Medicine, Mayo Clinic, Rochester, MN;
10. Department of Medicine, Stanford University, Stanford, CA;
11. Division of Experimental Oncology, Department of Onco-Hematology, Università Vita-Salute San Raffaele–Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan Italy;
12. Department of Biomedical Informatics, Harvard Medical School, Boston, MA;
13. Department of Data Science, Dana-Farber Cancer Institute, Boston, MA;
14. Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD;
15. Department of Academic Haematology, University College London, United Kingdom; and
16. Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Boston, MA